Isomorphic Labs, the AI drug discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV, and existing investor Google’s parent Alphabet, it said. The funding will accelerate further development of Isomorphic’s AI…
Category: AI drug discovery
AI, AI drug discovery, Biotech & Health, clinical trials, Fundraising, Global IT News, Global Security News, Lindus Health, Peter Thiel
Lindus Health raises $55M to ‘fix the broken clinical trial industry’
A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new…